journal article·2025

An assembly modules deformation strategy improved the chemical stability and self-assembly stability of docetaxel prodrugs nanoassemblies

Wenjing Wang, Shuo Wang, Shengyao Xu, Rong Chai, Jun Yuan, Hao Zhang, Yaqi Li, Xiaohui Pu, Xin Li, Jin Sun, Zhonggui He, Bingjun Sun

Nanoscale· Volume 17· Issue 12
Publisher page

Abstract

Self-assembly prodrugs usually consist of drug modules, activation modules, and assembly modules. The selection of suitable modules to construct prodrug nanoassemblies with self-assembly stability and "intelligent" activation is a challenge. As a common assembly module, oleic acid can provide a driving force and steric hindrance for prodrugs self-assembly. However, the unsaturated double bond of oleic acid is readily oxidized and it affects its chemical stability. Herein, two docetaxel (DTX) prodrugs were designed using disulfide bonds as activation modules and two different fatty acids (isostearic acid and oleic acid) as assembly modules, respectively. Compared with oleic acid, isostearic acid had higher chemical stability. Simultaneously, the terminal propyl structure of isostearic acid compensated for the steric hindrance without a double bond. Overall, this structural deformation improved the self-assembly ability and chemical stability of the prodrug nanoassemblies, thus balancing the effectiveness and safety of the prodrugs. Our findings reveal the importance of the assembly modules and provide a guidance for the rational design of prodrug nanoassemblies.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Innovative Microfluidic and Catalytic Techniques Innovation · Nanoparticle-Based Drug Delivery · Cancer Treatment and Pharmacology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, No. 59 Mailbox, 103 Wenhua Road, Shenyang, 110016, China

Peking Union Second Pharmaceutical Factory Ltd, Beijing 102600, China

State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, N. Jinming Ave., Kaifeng 475004, China

Department of Respiratory Disease, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China

Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, China

Funding

Liaoning Revitalization Talents Program · National Natural Science Foundation of China · Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program

References (46)

Show source-provided references
1. Bocci · Nat. Rev. Clin. Oncol. · 2016 · 13 · 65910.1038/nrclinonc.2016.64 ↗
2. Hellmann · Ann. Oncol. · 2016 · 27 · 182910.1093/annonc/mdw271 ↗
3. Ishida · Thorac. Cancer · 2022 · 13 · 17310.1111/1759-7714.14236 ↗
4. Li · Small · 2021 · 17 · 210146010.1002/smll.202101460 ↗
5. Liu · Nat. Commun. · 2022 · 13 · 722810.1038/s41467-022-35033-7 ↗
6. Zhang · Acta Pharm. Sin. B · 2021 · 11 · 226510.1016/j.apsb.2021.03.033 ↗
7. Anselmo · Bioeng. Transl. Med. · 2019 · 4 · e1014310.1002/btm2.10143 ↗
8. Anselmo · Bioeng. Transl. Med. · 2021 · 6 · e1024610.1002/btm2.10246 ↗
9. Mitchell · Nat. Rev. Drug Discovery · 2021 · 20 · 10110.1038/s41573-020-0090-8 ↗
10. Dai · Chem. Soc. Rev. · 2017 · 46 · 383010.1039/C6CS00592F ↗
11. He · Acc. Chem. Res. · 2019 · 52 · 244510.1021/acs.accounts.9b00228 ↗
12. Vargason · Nat. Biomed. Eng. · 2021 · 5 · 95110.1038/s41551-021-00698-w ↗
13. de Lázaro · Nat. Mater. · 2021 · 20 · 146910.1038/s41563-021-01047-7 ↗
14. Zoulikha · Chin. Chem. Lett. · 2025 · 36 · 11022510.1016/j.cclet.2024.110225 ↗
15. Yang · Nano-Micro Lett. · 2021 · 12 · 182
16. Hayoung · ACS Nano · 2023 · 17 · 1233610.1021/acsnano.3c01503 ↗
17. Seri · ACS Appl. Bio Mater. · 2022 · 4 · 3145
18. Lingling · J. Controlled Release · 2020 · 328 · 32510.1016/j.jconrel.2020.08.062 ↗
19. Lai · Chin. J. Nat. Medicines · 2024 · 22 · 110.1016/S1875-5364(24)60574-1 ↗
20. Zhang · Adv. Sci. · 2021 · 8 · 210145410.1002/advs.202101454 ↗
21. Li · Asian J. Pharm. Sci. · 2022 · 17 · 241
22. Li · Acta Mater. Med. · 2023 · 2 · 54
23. Wang · Acta Pharm. Sin. B · 2024 · 14 · 140010.1016/j.apsb.2023.09.017 ↗
24. Liu · Chin. Chem. Lett. · 2023 · 34 · 10751810.1016/j.cclet.2022.05.032 ↗
25. Zhang · J. Mater. Chem. B · 2016 · 4 · 384210.1039/C6TB90070D ↗
26. Zhou · J. Controlled Release · 2020 · 328 · 61710.1016/j.jconrel.2020.09.035 ↗
27. Wan · Proc. Natl. Acad. Sci. U. S. A. · 2023 · 120 · e221038512010.1073/pnas.2210385120 ↗
28. Qiu · Discover Oncol. · 2024 · 15 · 63010.1007/s12672-024-01410-5 ↗
29. Canyu · ACS Nano · 2024 · 18 · 3509110.1021/acsnano.4c09256 ↗
30. Da-Yong · ACS Nano · 2024 · 18 · 3550710.1021/acsnano.4c12967 ↗
31. Xian · Cancer Res. · 2024 · 84 · 304410.1158/0008-5472.CAN-23-3511 ↗
32. Sun · Nat. Commun. · 2019 · 10 · 321110.1038/s41467-019-11193-x ↗
33. Sun · Nano Lett. · 2018 · 18 · 364310.1021/acs.nanolett.8b00737 ↗
34. Sun · Acta Biomater. · 2019 · 92 · 21910.1016/j.actbio.2019.05.008 ↗
35. Sun · Acta Biomater. · 2023 · 157 · 41710.1016/j.actbio.2022.12.005 ↗
36. Xue · Exploration · 2022 · 2 · 2021013410.1002/EXP.20210134 ↗
37. Wang · Nano Res. · 2022 · 15 · 336710.1007/s12274-021-3895-9 ↗
38. Wang · ACS Appl. Mater. Interfaces · 2022 · 14 · 5120010.1021/acsami.2c14523 ↗
39. Li · Nano Res. · 2024 · 17 · 290810.1007/s12274-023-6081-4 ↗
40. Xu · J. Controlled Release · 2023 · 360 · 78410.1016/j.jconrel.2023.07.012 ↗
41. Yang · Nano Lett. · 2023 · 23 · 111910.1021/acs.nanolett.2c03286 ↗
42. Garg · Mycoses · 1993 · 36 · 5110.1111/j.1439-0507.1993.tb00687.x ↗
43. Zhang · Chin. J. Polym. Sci. · 2024 · 42 · 54410.1007/s10118-024-3072-1 ↗
44. Zaro · AAPS J. · 2015 · 17 · 8310.1208/s12248-014-9670-z ↗
45. Wu · ACS Catal. · 2023 · 13 · 907810.1021/acscatal.3c01469 ↗
46. Li · Nano Lett. · 2023 · 24 · 39410.1021/acs.nanolett.3c04182 ↗